Feasibility of Monitoring Patients Who Have Cancer With a Smart T-shirt: Protocol for the OncoSmartShirt Study

Emma Balch Steen-Olsen, Helle Pappot, Allan Green, Henning Langberg, Cecilie Holländer-Mieritz, Emma Balch Steen-Olsen, Helle Pappot, Allan Green, Henning Langberg, Cecilie Holländer-Mieritz

Abstract

Background: Studies have shown that there may be dissimilar perceptions on symptoms or side effects between patients with cancer and health care professionals. This may lead to symptomatic patients notifying the clinic irregularly or not telling the clinic at all. Wearables could help identify symptoms earlier. Patients with low socioeconomic status and less self-awareness of their health may benefit from this. A new design of wearables is a smart t-shirt that, with embedded sensors, provides measurement flows such as electrocardiogram, thoracic and abdominal respiration, and temperature.

Objective: This study evaluates the feasibility of using a smart t-shirt for home monitoring of biometric sensor data in adolescent and young adult and elderly patients during cancer treatment.

Methods: The OncoSmartShirt study is an explorative study investigating the feasibility of using the Chronolife smart t-shirt during cancer treatment. This smart t-shirt is designed with multiple fully embedded sensors and electrodes that engender 6 different measurement flows continuously. A total of 20 Danish patients with cancer ≥18 years old in antineoplastic treatment at Department of Oncology Rigshospitalet Denmark will be recruited from all cancer wards, whether patients are in curative or palliative care. Of these 20 patients, 10 (50%) will be <39 years old, defined as adolescent and young adult, and 10 (50%) will be patients >65 years old, defined as elderly. Consenting patients will be asked to wear a smart t-shirt daily for 2 weeks during their treatment course.

Results: The primary outcome is to determine if it is feasible to wear a smart t-shirt throughout the day (preferably 8 hours per day) for 2 weeks. Inclusion of patients started in March 2022.

Conclusions: The study will assess the feasibility of using the Chronolife smart t-shirt for home monitoring of vital parameters in patients with cancer during their treatment and bring new insights into how wearables and biometric data can be used as part of symptom or side-effect recognition in patients with cancer during treatment, with the aim to increase patients' quality of life.

Trial registration: ClinicalTrials.gov NCT05235594; https://beta.clinicaltrials.gov/study/NCT05235594.

International registered report identifier (irrid): PRR1-10.2196/37626.

Keywords: adolescent; biometric sensor technology; cancer; cancer treatment; health care professional; home monitoring; patient; patient-generated health data; protocol; remote monitoring; sensor; smart t-shirt; youth.

Conflict of interest statement

Conflicts of Interest: None declared.

©Emma Balch Steen-Olsen, Helle Pappot, Allan Green, Henning Langberg, Cecilie Holländer-Mieritz. Originally published in JMIR Research Protocols (https://www.researchprotocols.org), 03.10.2022.

Figures

Figure 1
Figure 1
Data flow from data collected by the t-shirt to the smartphone app to the accredited data hosting server. Illustration made public with allowance from Chronolife. GDPR: General Data Protection Regulation.

References

    1. Beauchamp UL, Pappot H, Holländer-Mieritz C. The Use of Wearables in Clinical Trials During Cancer Treatment: Systematic Review. JMIR Mhealth Uhealth. 2020 Nov 11;8(11):e22006. doi: 10.2196/22006. v8i11e22006
    1. Kofoed S, Breen S, Gough K, Aranda S. Benefits of remote real-time side-effect monitoring systems for patients receiving cancer treatment. Oncol Rev. 2012 Mar 05;6(1):e7. doi: 10.4081/oncol.2012.e7. doi: 10.4081/oncol.2012.e7.oncol.2012.e7
    1. Beg MS, Gupta A, Stewart T, Rethorst CD. Promise of Wearable Physical Activity Monitors in Oncology Practice. J Oncol Pract. 2017 Feb;13(2):82–89. doi: 10.1200/JOP.2016.016857.
    1. Jim HSL, Hoogland AI, Brownstein NC, Barata A, Dicker AP, Knoop H, Gonzalez BD, Perkins R, Rollison D, Gilbert SM, Nanda R, Berglund A, Mitchell R, Johnstone PAS. Innovations in research and clinical care using patient-generated health data. CA Cancer J Clin. 2020 May;70(3):182–199. doi: 10.3322/caac.21608. doi: 10.3322/caac.21608.
    1. Chung AE, Jensen RE, Basch EM. Leveraging Emerging Technologies and the "Internet of Things" to Improve the Quality of Cancer Care. J Oncol Pract. 2016 Oct;12(10):863–866. doi: 10.1200/JOP.2016.015784. JOP.2016.015784
    1. Liao Y, Thompson C, Peterson S, Mandrola J, Beg MS. The Future of Wearable Technologies and Remote Monitoring in Health Care. Am Soc Clin Oncol Educ Book. 2019 Jan;39:115–121. doi: 10.1200/EDBK_238919.
    1. Reilly CM, Bruner DW, Mitchell SA, Minasian LM, Basch E, Dueck AC, Cella D, Reeve BB. A literature synthesis of symptom prevalence and severity in persons receiving active cancer treatment. Support Care Cancer. 2013 Jun 12;21(6):1525–50. doi: 10.1007/s00520-012-1688-0.
    1. Moreira-Pinto J, Leão I, Palmela C, Branco F, Godinho J, Simões P, Leal-Costa L, Lopes F, Faria A, Casa-Nova M, Escária A, Costa F, Galvão I, Teixeira J, Passos-Coelho J. Febrile Neutropenia in Patients with Solid Tumors Undergoing Intravenous Chemotherapy. Oncol Res Treat. 2020 Aug 20;43(11):605–612. doi: 10.1159/000506109. 000506109
    1. Niraula S, Seruga B, Ocana A, Shao T, Goldstein R, Tannock IF, Amir E. The Price We Pay for Progress: A Meta-Analysis of Harms of Newly Approved Anticancer Drugs. JCO. 2012 Aug 20;30(24):3012–3019. doi: 10.1200/jco.2011.40.3824.
    1. Piwek L, Ellis DA, Andrews S, Joinson A. The Rise of Consumer Health Wearables: Promises and Barriers. PLoS Med. 2016 Feb;13(2):e1001953. doi: 10.1371/journal.pmed.1001953. PMEDICINE-D-15-00616
    1. Dias D, Paulo Silva Cunha J. Wearable Health Devices-Vital Sign Monitoring, Systems and Technologies. Sensors (Basel) 2018 Jul 25;18(8):2414. doi: 10.3390/s18082414. s18082414
    1. Low CA, Dey AK, Ferreira D, Kamarck T, Sun W, Bae S, Doryab A. Estimation of Symptom Severity During Chemotherapy From Passively Sensed Data: Exploratory Study. J Med Internet Res. 2017 Dec 19;19(12):e420. doi: 10.2196/jmir.9046. v19i12e420
    1. Sonn GA, Sadetsky N, Presti JC, Litwin MS. Differing perceptions of quality of life in patients with prostate cancer and their doctors. J Urol. 2013 Jan;189(1 Suppl):S59–65; discussion S65. doi: 10.1016/j.juro.2012.11.032.S0022-5347(12)05497-3
    1. Litwin MS, Lubeck DP, Henning JM, Carrol PR. Differences in urologist and patient assessments of health related quality of life in men with prostate cancer: Results of the CaPSURE database. Journal of Urology. 1998 Jun;159(6):1988–1992. doi: 10.1016/s0022-5347(01)63222-1.
    1. Xiao C, Polomano R, Bruner D. Comparison between patient-reported and clinician-observed symptoms in oncology. Cancer Nurs. 2013;36(6):E1–E16. doi: 10.1097/NCC.0b013e318269040f.
    1. Smart textile. Chronolife. [2022-09-19]. .
    1. Steinberg C, Philippon F, Sanchez M, Fortier-Poisson P, O'Hara G, Molin F, Sarrazin J, Nault I, Blier L, Roy K, Plourde B, Champagne J. A Novel Wearable Device for Continuous Ambulatory ECG Recording: Proof of Concept and Assessment of Signal Quality. Biosensors (Basel) 2019 Jan 21;9(1):17. doi: 10.3390/bios9010017. bios9010017
    1. Fouassier D, Roy X, Blanchard A, Hulot J. Assessment of signal quality measured with a smart 12-lead ECG acquisition T-shirt. Ann Noninvasive Electrocardiol. 2020 Jan 24;25(1):e12682. doi: 10.1111/anec.12682.
    1. Tsukada YT, Tokita M, Murata H, Hirasawa Y, Yodogawa K, Iwasaki Y, Asai K, Shimizu W, Kasai N, Nakashima H, Tsukada S. Validation of wearable textile electrodes for ECG monitoring. Heart Vessels. 2019 Jul 24;34(7):1203–1211. doi: 10.1007/s00380-019-01347-8. 10.1007/s00380-019-01347-8
    1. Cox SM, Lane A, Volchenboum SL. Use of Wearable, Mobile, and Sensor Technology in Cancer Clinical Trials. JCO Clin Cancer Inform. 2018 Dec;2:1–11. doi: 10.1200/CCI.17.00147.
    1. Basch E, Deal AM, Kris MG, Scher HI, Hudis CA, Sabbatini P, Rogak L, Bennett AV, Dueck AC, Atkinson TM, Chou JF, Dulko D, Sit L, Barz A, Novotny P, Fruscione M, Sloan JA, Schrag D. Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial. J Clin Oncol. 2016 Feb 20;34(6):557–65. doi: 10.1200/JCO.2015.63.0830. JCO.2015.63.0830
    1. Komarzynski S, Wreglesworth NI, Griffiths D, Pecchia L, Subbe CP, Hughes SF, Davies EH, Innominato PF. Embracing Change: Learnings From Implementing Multidimensional Digital Remote Monitoring in Oncology Patients at a District General Hospital During the COVID-19 Pandemic. JCO Clinical Cancer Informatics. 2021 Dec;(5):216–220. doi: 10.1200/cci.20.00136.
    1. Lu T, Fu C, Ma MH, Fang C, Turner AM. Healthcare Applications of Smart Watches. A Systematic Review. Appl Clin Inform. 2016 Sep 14;7(3):850–69. doi: 10.4338/ACI-2016-03-R-0042. 2016-03-R-0042
    1. Reeder B, David A. Health at hand: A systematic review of smart watch uses for health and wellness. J Biomed Inform. 2016 Oct;63:269–276. doi: 10.1016/j.jbi.2016.09.001. S1532-0464(16)30113-7
    1. Chronolife product description. Chronolife. [2022-09-19]. .
    1. Cnossen IC, van Uden-Kraan CF, Rinkel RN, Aalders IJ, de Goede CJ, de Bree R, Doornaert P, Rietveld DH, Langendijk JA, Witte BI, Leemans CR, Verdonck-de Leeuw IM. Multimodal guided self-help exercise program to prevent speech, swallowing, and shoulder problems among head and neck cancer patients: a feasibility study. J Med Internet Res. 2014 Mar 06;16(3):e74. doi: 10.2196/jmir.2990. v16i3e74
    1. Wu R, Liaqat D, de Lara E, Son T, Rudzicz F, Alshaer H, Abed-Esfahani P, Gershon AS. Feasibility of Using a Smartwatch to Intensively Monitor Patients With Chronic Obstructive Pulmonary Disease: Prospective Cohort Study. JMIR Mhealth Uhealth. 2018 Jun 14;6(6):e10046. doi: 10.2196/10046. v6i6e10046
    1. Holländer-Mieritz C, Vogelius I, Kristensen C, Green A, Rindum J, Pappot H. Using Biometric Sensor Data to Monitor Cancer Patients During Radiotherapy: Protocol for the OncoWatch Feasibility Study. JMIR Res Protoc. 2021 May 13;10(5):e26096. doi: 10.2196/26096. v10i5e26096

Source: PubMed

Sponsorer og samarbejdspartnere

Medicinske tilstande

Narkotikainterventioner

3
Abonner